Charles Schwab’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $454K | Buy |
85,817
+21,602
| +34% | +$114K | ﹤0.01% | 3167 |
|
|
2025
Q1 | $523K | Sell |
64,215
-6,690
| -9% | -$54.5K | ﹤0.01% | 3074 |
|
|
2024
Q4 | $908K | Hold |
70,905
| – | – | ﹤0.01% | 2948 |
|
|
2024
Q3 | $760K | Hold |
70,905
| – | – | ﹤0.01% | 3006 |
|
|
2024
Q2 | $562K | Buy |
70,905
+3,605
| +5% | +$28.6K | ﹤0.01% | 3147 |
|
|
2024
Q1 | $1.08M | Sell |
67,300
-1,732
| -3% | -$27.8K | ﹤0.01% | 2772 |
|
|
2023
Q4 | $947K | Hold |
69,032
| – | – | ﹤0.01% | 2848 |
|
|
2023
Q3 | $1.01M | Buy |
69,032
+1,507
| +2% | +$22K | ﹤0.01% | 2795 |
|
|
2023
Q2 | $1.15M | Buy |
67,525
+57,471
| +572% | +$978K | ﹤0.01% | 2714 |
|
|
2023
Q1 | $140K | Hold |
10,054
| – | – | ﹤0.01% | 3207 |
|
|
2022
Q4 | $66.4K | Hold |
10,054
| – | – | ﹤0.01% | 3310 |
|
|
2022
Q3 | $53K | Hold |
10,054
| – | – | ﹤0.01% | 3320 |
|
|
2022
Q2 | $48K | Sell |
10,054
-53,225
| -84% | -$254K | ﹤0.01% | 3396 |
|
|
2022
Q1 | $537K | Buy |
63,279
+1,201
| +2% | +$10.2K | ﹤0.01% | 3078 |
|
|
2021
Q4 | $744K | Sell |
62,078
-164
| -0.3% | -$1.97K | ﹤0.01% | 3021 |
|
|
2021
Q3 | $1.1M | Buy |
62,242
+1,587
| +3% | +$28.1K | ﹤0.01% | 2837 |
|
|
2021
Q2 | $1.25M | Buy |
+60,655
| New | +$1.25M | ﹤0.01% | 2854 |
|